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A STUDY OF THE HUMAN PAPILLOMA VIRUS AND THE HUMAN 
PAPILLOMA VIRUS VACCINE IN THE AFRICAN AMERICAN COMMUNITY  
KIA DANDRIELLE KENEBREW 
ABSTRACT 
African Americans have higher rates of HPV-related cancer incidence than 
other ethnicities.  A review of 18 studies completed on African Americans and 
people of African descent was done.  African Americans do, in fact have higher 
rates of HPV-related cancer than other racial groups.  The disparity appears to 
be decreasing over time with increased distribution of knowledge about the 
human papillomavirus to African American groups.  However, studies show that 
many African American communities lack essential knowledge about the severity 
of HPV-related cancer, HPV transmission and commonality, and the HPV 
vaccine itself.   
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 1 
Introduction 
 Sexually transmitted diseases and infections affect large numbers of the 
U.S. population.  It has been found that African Americans are affected by many 
diseases at different rates than other ethnicities and races.  The U.S. Black 
population has been shown to be disproportionately affected by STDs and STI’s, 
as well.  The sexually transmitted infection known as human papillomavirus 
affects larger percentages of the African American compared to other races.  The 
mortality rate of cervical cancer among African American women is higher 
compared to other races.  It is important to understand the cause behind these 
disparities because with knowledge proper interventions can be developed.  
These inconsistencies have continued to exist even with the development of HPV 
vaccines and its approval for use in men and women.  Overtime, disparities have 
decreased in size but they still continue to exist.  Potential causes of these 
disparities found can be availability, attitude towards medical providers, attitude 
towards the vaccine or knowledge of the virus and its related cancers.  
Decreases in illness in any community can lessen the financial burden placed 
upon society as a whole.  
 
Specific Aims 
         The aim of this thesis is to investigate the perception and attitudes of 
African Americans towards human papillomavirus (HPV) and the human 
papillomavirus vaccine.  Treatments of the physical symptoms of active human 
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papillomavirus infection are accessible to patients.  There is no cure for the viral 
infection if it is not cleared by the patient’s body on its own.  Preventative care, in 
the form of a vaccine, has been developed and protects against a multitude of 
the viral strains of human papillomavirus strains.  Administration of the vaccine, 
to both males and females, is encouraged due to the potentially carcinogenic 
effect of the virus in both genders.  The goal of this thesis is to explore how 
perceptions of the human papillomavirus and vaccine affect its reception and, 
ultimately, its uptake amongst African American people. 
 
Background 
About HPV 
HPV is known as human papillomavirus.  Human papillomavirus is the 
most common sexually transmitted infection in the United States.  79 million 
Americans are known to be infected with HPV(1).  Most of those infected are in 
their late teens and early 20s.  There are many different types of HPV. The 
different variations of the virus are known as strains and the different strains are 
identified by number.  There are over 100 strains of HPV and around 40 of those 
strains are known to be transmitted sexually (2).  Some strains of HPV cause 
papillomas (for which the virus is named).  A papilloma is a type of wart (2).  The 
virus primarily infects epithelial cells of the body, located on the surface of the 
skin, vagina, anus, vulva, cervix, glans penis head, mouth and throat(2).   
The 40 sexually transmitted strains of HPV are split into two categories: 
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the high risk category and the low risk category.  The high risk strains include: 
16, 18, 31, 33, 45, 52 and 58(2).  These strains are considered oncogenic, 
meaning that they have an increased risk of mutating into cancer over time (3).  
70% of cervical cancers are caused by strains 16 and 18.  Low risks strains, such 
as 6 and 11, are linked to about 90% of genital warts and these strains are 
unlikely to develop into cancer(2).    
HPV is spread via vaginal, anal, or oral sex with a previously HPV infected 
partner (2).  The current most common methods of transmission are vaginal or 
anal sex (4).  HPV can be spread even if the carrier is not showing symptoms, 
which contributes to how widespread the disease is along with the fact that the 
virus can sometimes have an extremely long incubation period (2,5).  Infection with 
HPV generally is asymptomatic and self-limited but can result in a variety of HPV 
type-specific clinical consequences (6).  
 Many people infected with HPV never experience symptoms and for a lot 
of patients, the virus clears the body on its own (2).  Some people show physical 
symptoms of viral contraction (i.e., warts) within weeks after infection (2).  While, 
still others do not develop symptoms for several years (2).  If symptoms develop, 
they are usually genital warts, also known as papillomas (2).  These usually 
appear as a small bump or group of bumps in the genital area (2).  As stated 
before, certain strains of the virus can be carcinogenic.  Not only can certain viral 
strains lead to cervical cancer but they can cause other cancers as well.  These 
cancers include cancer of the vulva, vagina, penis, or anus (2).  Some strains can 
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also lead to the development of cancer in the back of the throat, including the 
base of the tongue and tonsils (2).  Cancer in this location is known as 
oropharyngeal cancer (2).  Cancer often takes years, even decades, to develop 
after a person gets HPV.  The carcinogenic strains are not always guaranteed to 
lead to the development of cancer but they do increase the likelihood of 
development (2).  People with weak immune systems (including those with 
HIV/AIDS) may be less able to fight off HPV and clear the virus (2).  Therefore, 
immunocompromised patients are even more likely to develop the associated 
health problems and maybe more likely to develop health problems from HPV. 
About 14 million people become newly infected each year (4).  The CDC 
estimates that HPV contributes to 74% of the new STIs in the United States 
every year (7).  HPV is so common that almost every person who is sexually-
active will contract HPV at some point in their life, if they do not receive the HPV 
vaccine (2).  Before HPV vaccines, around 340,000 to 360,000 women and men 
were affected by genital warts caused by HPV every year (4).  About one in 100 
sexually active U.S adults has genital warts at any given time (4).  However, this 
could be an underestimate because these statistics are only based on those who 
sought medical treatment. 12,000 women living in the U.S. are diagnosed with 
cervical cancer and, yearly, more than 4,000 women die from cervical cancer (4).  
An estimate of 19,400 women and 12,100 men are diagnosed with HPV-related 
cancers (4).  In the United States, 23,700 women and 17,300 men are diagnosed 
with a cancer caused by HPV infection (4).  Cervical cancer is routinely screened 
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for but there are no recommended cancer screening tests for the other 20,000 
cases of cancers caused by HPV infections.  The cancers not screened for often 
go undetected until the later stages.  Yearly, around 39,800 new cases of cancer 
are found in areas of the body that HPV infects (4).  HPV is the cause of about 
31,500 of these cancers (4).  Cervical cancer is the most common HPV-
associated cancer among women, and oropharyngeal cancers are the most 
common among men (2,4).  The oral infection rate of HPV in men was found to be 
11.5%, which is 3 times the prevalence in women (7) 
HPV Known Mechanism of Infection 
Human papillomaviruses have evolved to have an extremely slow 
infectious process (5).  This is thought to be due to the fact that these viruses 
have a unique mechanism of infection that has most likely evolved to limit 
infection to the basal cells of stratified epithelium (5).  These basal cells are the 
only tissue in which the virus can replicate (5).  En vivo, infection is limited to 
areas of epithelial disruption (5).  The immune response mechanisms of the host, 
given that the immune system is not compromised, would likely be focused on 
protecting the damaged sites (5).  In mouse models, the epithelium was found to 
be repaired, by the body, within 1–2 days (5).  So, a delay of 1–2 days in the 
initiation of viral gene expression probably allows for the virus to escape being 
destroyed by the body’s initial immune response to infection (5).  Human 
papillomaviruses are the only viruses that begin their infectious process at an 
extracellular site (5).  The virus cannot immediately bind to its preferred epithelial 
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cells when it initially enters the body (5).  It must first bind to heparan sulfate 
proteoglycans on the basement membrane of the damaged epithelium (5,8).  
Figure 1 shows the virus binding at the disrupted basement membrane.  It binds 
to the basement membrane via its L1 major capsid protein (5).  Following binding, 
the virus then goes through a conformational change that leaves the N-terminus 
of the L2 minor capsid protein of the virus exposed (5).  This exposure allows for 
furin cleavage of the L2 protein (5,8). The proteolysis exposes an area of the L1 
protein that is then able to bind to a cell surface receptor on keratinocytes that 
are traveling across the basement membrane in an effort close the epithelial 
disruption (5).  It should be noted that this infection process is relatively slow 
compared to the infectious processes of other viruses.  The infectious process is 
remarkably slow and asynchronous (5).  It takes about 12–24 hours just to 
achieve transcription initiation (5,8).  
 
Figure 1. Model for Events Leading to in vivo Infection (8).  
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About HPV Vaccines 
The lengthy infectious process probably contributes to the exceptional 
effectiveness of L1- and L2-based prophylactic vaccines because the targets of 
the neutralizing antibodies maintain prolonged exposure of targets (8).  There are 
several vaccines on the market to protect against some of the 40 strains of 
sexually transmitted HPV.  Gardasil is a quadrivalent vaccine that protects 
against HPV strains 6, 11, 16 and 18 (9).  The vaccine contains HPV specific L1-
DNA fragment that are used in transcription to produce virus-like particles to 
stimulate an immune response (9).  Gardasil is given as three injections over a six-
month period (9).  The initial dose is given and then followed by another dose 2 
months later, and the third, six months after the first dose (9).  The vaccine is 
administered intramuscularly in the upper arm or thigh (9).  Gardasil was 
approved for use by females ages 9 through 26 by the FDA in 2006.  In 2009, the 
vaccine was approved, by the FDA, for use by males ages 9 through 26(10). 
 Cervarix is a bivalent vaccine that protects against types 16 and 18 (9). 
 Cervarix was approved for use for females ages 10 to 25 in the fall of 2009 (10). 
 Gardasil 9 is a 9-valent recombinant vaccine (9).  It protects against 9 
types of HPV that is Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 (9). These 9 types 
are responsible for the majority of HPV-related cancers and diseases (2).  It is 
extremely beneficial for protection against these high risk strains are delivered 
via one form of prophylaxis.   
These vaccines should be administered to all adolescents ages 11- 12 
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before they become sexually active (3).  Vaccines like Gardasil and Cervarix can 
tremendously reduce healthcare expenditures in the long run.  However, this 
outcome is only possible the vaccine is routinely administered to teens within the 
very crucial window of time between sexual understanding and sexual activity 
initiation.  The rate of uptake of the HPV vaccines can be affected by any number 
of factors.  Some factors have been identified and some have yet to be.  Culture, 
religion, access, knowledge are just a few aspects of patient life that can either 
positively or negatively affect vaccine uptake.  
 
Methods 
 This study was conducted by analyzing 18 research articles on human 
papillomavirus, the vaccine and people of African descent and African American 
people.  These studies identified were done in different locations across different 
types of populations.  The demographics of each study were analyzed and 
subsequently compared.  Statistics were evaluated for any disparities that may 
affect HPV vaccine uptake in people of African descent.  
 
Human Papillomavirus and Race 
Globally, cervical cancer is among the top 5 cancers that affect women.  It 
is one of the top ten cancers that Black women in America are most likely to be 
diagnosed with (10).  Strains of HPV are responsible for 99.7% of cervical cancer 
cases (11). Cervical cancer is the second most common malignant disease among 
 9 
women in the United States (11).  It is responsible for approximately 4000 deaths 
per year (11).  Over 25% of females between the ages of 14 and 59 years are 
infected with at least one strain of HPV (11).  The virus is prominent in men, as 
well.  Oral HPV infections, which can cause certain oropharyngeal squamous cell 
carcinomas, are more common in men than women (11).  Infection prevalence has 
been found to be around 45.2% in males (12).  In 2006, a vaccine was approved 
for use among females between the ages of 9 and 26 years (11).  HPV vaccine 
guidelines were later extended to males in October of 2009, with routine 
vaccination recommendations beginning in October 2011 (11).  African American 
and Hispanic women exhibit higher rates of cervical cancer than their non-
Hispanic White counterparts (11).   African American females, along with Hispanic 
females, appear to be less likely than non-Hispanic Whites to have initiated and 
completed the HPV vaccine series (11).  Studies have found evidence to suggest 
that non-Hispanic White parents are less likely to vaccinate their sons than 
parents of other racial and ethnic groups (11).  Receiving a recommendation from 
a healthcare provider to vaccinate against HPV can increase the likelihood of a 
patient to receive the prophylactic vaccine.  The statistics, previously stated, 
motivate more research on vaccine uptake amongst different minority groups.  A 
study on race trends used the fundamental cause theory of health disparities to 
search for potential social inequalities in, both, patient HPV vaccine knowledge 
and patient receipt of recommendation to vaccinate (11).  The fundamental cause 
theory assumes that health inequalities emerge and persist in society because of 
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the unequal distribution of health-beneficial resources (11).  Meaning, those who 
are more socially advantaged in any area of knowledge, money, status, and 
social connections tend to have greater access to health promoting innovations.  
This is the justification behind the idea that people of African descent have lower 
HPV vaccine uptake and lower general HPV knowledge than other races and 
ethnicities.  It has been found that African Americans are less likely to receive a 
recommendation from a health professional to vaccinate their daughters (11).  
Data was collected from a large, nationally representative sample of parents of 
adolescent children to examine racial and ethnic trends in HPV vaccination 
uptake and provider recommendations (11).  The National Center for Immunization 
and Respiratory Diseases and the National Center for Health Statistics 
completed a telephone survey on a random digit sample of parents with 
adolescent children (11).  There are three well represented groups in the sample 
surveyed: Hispanic (13%), Black (10%), and non-Hispanic White (69%) (11).  8% 
of the sample was in the ‘Other’ ethnic category (11).   African American 
adolescents in the study were had the lowest percentage of HPV vaccine 
initiation at 40% (11).  Provider recommendation of the vaccine appeared low 
among African Americans females at 52% compared to 61% among non-
Hispanic White females (11).  24% of Black and Hispanic adolescents initiated the 
HPV vaccine while the non-Hispanic White population had only 12% initiation, in 
the study (11).  The percentage of healthcare provider recommendations to 
vaccinate in the male population is slightly higher in the minority ethnicity group, 
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however recommendations to males overall are generally lower compared to 
females (11).  
Less than 50% of females studied received a provider recommendation to 
vaccinate in 2008 and that number increased to approximately 70% in 2013 (11).  
Based upon Figure 2, the demographic break down showed that 72% of non-
Hispanic White teenage females received recommendations and 65% of Black 
and 65% Hispanic teenage females received recommendations (11).  In teen boys 
the recommendations jumped from 5% in 2010 to about 43% in 2013 (11).   Black 
teen males were more likely to receive a recommendation to vaccinate with 
recommendation occurrences at 47% versus their Hispanic counterparts at 43% 
and their non-Hispanic White counterparts at 43%(11).  Table 1 shows the 
descriptive statistics of the study.  The majority of adolescents who participated 
were ages 14-15 years of age(11).  10.16% of the participants in this study were 
Black (11). Table 1 shows vaccine recommendation was lower in Black teen girls 
than in White teen girls at statistically significant levels (P<0.05). Vaccine uptake 
was lower in Black teenage girls, than in White and Hispanic teenage girls at 
statistically significant levels (P<0.05).  Table 1 also shows that vaccine 
recommendation for Black teenage boys was higher than vaccine 
recommendation for White teenage boys at statistically significant levels and 
numbers were not statistically significant to show a difference in vaccine 
recommendation levels between Hispanic and Black boys (P<0.05).  Vaccine 
uptake was lower in Black boys than Hispanics at statistically significant levels 
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(P<0.05).  However, vaccine uptake was higher in Black boys when compared to 
White boys at statistically significant levels (P<0.05).      
Table 1-Descriptive Statistics (mean/percentage ±SD), National Immunization 
Survey-Teen 
 Femalesa Malesb 
 1 2 3 4 5 6 7 8 
 Full 
Sample 
(n=77,389) 
Hispanicc 
(n= 
10,188) 
Blackd 
(n= 
7846) 
Whitee 
(n= 
53,109) 
Full 
Sample 
(n= 
56,632) 
Hispanicf 
(n=7512) 
Blackg 
(n= 
5338) 
Whiteh 
(n= 
39,102) 
Vaccine 
Uptake 44.10 48.24 39.62
c,e 43.79 13.94 19.65 18.08f,h 11.99 
Provider 
Recommend
ation 
59.04 53.54 51.84e 61.32 22.13 23.88 23.72h 21.45 
Race and 
Ethnicity 
        
Hispanic 13.16        
Black 10.16        
Non-
Hispanic 
White 
68.51        
Other 8.16        
Age in 
years 
14.97 
(-1.40) 
14.89 
(-1.40) 
14.99  
(-1.39) 
15 
(-1.40) 
14.99 
(-1.41) 
14.9 
(-1.39) 
14.98 
(-1.41) 
15.01 
(1.41) 
Federal 
poverty 
level (FPL) 
        
≥75k 45.79 24.86 24.9 53.11 46.37 24.96 25.78 53.58 
Greater than 
poverty, less 
than 75k 
41.12 41.41 47 40.24 40.37 40.48 47.23 39.4 
Below 
federal 
poverty level 
13.08 33.73 28.1 6.65 13.35 34.56 27 7.02 
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Mothers 
Education 
        
Less than 
high school 7.95 28.31 8.83 3.99 7.6 28.12 8.97 3.57 
High School 
only 18.2 20.35 23.92 17.01 17.94 21.98 22.63 16.51 
Some 
college 29.71 26.29 35.16 29.83 28.87 24.45 34.32 29.07 
College 
graduate 44.34 25.06 32.1 49.18 45.59 25.45 34.08 50.85 
Mother 
respondent 83.09 86.01 87.68 82.47 80.23 84.05 85.5 79.69 
# of 
children in 
household 
1.7 
(-0.63) 
1.83 
(-.65) 
1.72 
(-0.66) 
1.67   
(-0.62) 
1.7 
(-0.63) 
1.81 
(-0.63) 
1.72 
(-0.66) 
1.67 
(-0.62) 
Married 76.7 69.39 46.45 82.89 77.3 70.53 47.77 82.95 
Mother’s 
age in years 
        
 
35 or 
younger 
7.06 12.59 14.11 4.81 6.85 12.69 12.8 4.75 
35-44 42.33 50.18 45.41 40.52 41.68 49.67 46.67 39.29 
45 or older 50.61 37.23 40.48 54.67 51.48 37.65 40.54 55.96 
Census 
Region 
        
South 36.09 41.72 59.1 32.38 36.41 42.35 58.64 32.84 
Midwest 22.27 12.87 17.9 25.39 21.26 11.58 16.8 24.44 
West 22.65 31.65 5.01 21.83 23.43 32.44 5.79 22.25 
Northeast 18.99 13.76 17.98 20.5 18.9 13.63 18.77 20.47 
a2008-2013, b2010-2013 shown are variable, means/proportions, and standard 
deviations (SD).  Additional superscripts identify significant differences in the dependent 
variables between designated classes (z-score, P<0.05) 
Note: Reprinted from Burdette, Amy M., Webb, Noah S., Hill, Terrence D., Jokinen-
Gordon, H. “Race-specific trends in HPV vaccinations and provider recommendations: 
persistent disparities or social progress?” Public Health 142 (2017) p170. 20 June 2018. 
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  Figure 2 shows that from 2008 to 2013, all groups seen an increase in 
HPV vaccination recommendation, including Black males and females. However, 
recommendations to Black males and females are still just under 50%. 
 
Figure 2. Proportion of Sample Receiving a Recommendation to Vaccinate By Year (11).  
 
As shown in Figure 3,  more than half of the entire female population 
studied had received at least one dose of the HPV vaccine by 2013 (11).  The 
proportion of ≥ 1 dose recipients was higher in the Hispanic teen population, at a 
percentage of 57%, than for both non-Hispanic Whites at 49% and African 
Americans who also had a percentage of 49% (11).  Among males, less than 2% 
had initiated the vaccine in 2010 but this number drastically increased to 
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approximately 29% by 2013 (11).  HPV vaccine uptake trends among adolescent 
males shows that with Blacks and Hispanics there are higher rates of 
vaccination, both at 36%, compared to non-Hispanic Whites at 27% (11).  
 
Figure 3. Proportion of Sample Receiving at Least One Dose of HPV Vaccine by 
Year(11).  
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Table 2-Logistic Regression Estimates for Females Predicting Provider 
Recommendation, National Immunization Survey-Teen 
 Full Sample 
(n=77,389) 
Hispanic 
(n=10,188) 
Black 
(n=7864) 
White 
(n=53,019) 
 Model 1 Model 2 Model 3 Model 4 Model 5 
Year 1.19*** 1.18*** 1.21*** 1.26*** 1.17*** 
aRace      
Hispanic 0.97 0.91*    
Black 0.79*** 0.68***    
Other 0.94* 0.91    
Age 1.07*** 1.07*** 1.04* 1.04* 1.07* 
bIncome Household       
≥75k 1.80*** 1.80*** 1.63*** 1.45*** 1.85*** 
Greater than poverty, 
<75k 1.23*** 1.23*** 1.17** 1.29*** 1.25*** 
cMother’s Education      
Less than high school 0.51*** 0.51*** 0.42*** 0.59*** 0.59*** 
High School only 0.66*** 0.66*** 0.66** 0.68*** *0.65** 
Some college 0.79*** 0.79*** 0.81** 0.90 0.76*** 
Mother Respondent 1.91*** 1.91*** 1.74*** 2.33*** 1.87*** 
Number of Children in 
Household 1.05*** 1.06*** 1.10** 1.03 1.05** 
Married 0.89*** 0.89*** 0.94 0.94 0.92** 
dMother’s age       
44 years-35 .89***0 0.89*** 0.92 0.84* 0.93 
≥45 years 0.86*** 0.86*** 0.79** 0.78** 0.91 
eCensus Region      
South 0.57*** 0.57*** 0.61*** 0.54*** 0.55*** 
Midwest 0.65*** 0.65*** 0.69*** 0.70*** 0.62*** 
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West 0.58*** 0.58*** 0.70** 0.70** 0.53*** 
Race Interaction      
Hispanic x year  1.03*    
Black x year  1.06***    
Other x year  1.01    
2do RuePs 0.05 0.05 0.06 0.06 0.05 
Hispanic), -White (non-2013; OR=odds ratio. Reference categories: a-Note: 2008
Northeast. -less than or equal to 34 yrs, e-college degree, d-poverty or less, c-b
)(11, P < 0.01**, P < 0.001***.P < 0.05* 
Note: Reprinted from Burdette, Amy M., Webb, Noah S., Hill, Terrence D., Jokinen-
Gordon, H. “Race-specific trends in HPV vaccinations and provider recommendations: 
persistent disparities or social progress?” Public Health 142 (2017) p172. 20 June 2018. 
According to data produced from one race-specific study, overtime the 
odds of receiving a recommendation to vaccinate have increased faster for Black 
and Hispanic women compared to their non-Hispanic White peers (11).  The 
increase in the odds of vaccination initiation, over the time period of this study, is 
greater for African Americans and Hispanic females than for non-Hispanic Whites 
(11).  Study results show that odds of HPV vaccination uptake increased more 
rapidly for minority females than for non-Hispanic White teens (11).  Table 2 
shows a 26% increase in likelihood of vaccination recommendation to Black teen 
females from 2008 to 2013 (P<0.001).  However, Table 2 showed that Black 
teenage females still had less of a likelihood of HPV vaccine recommendation 
when compared directly to White females.  The overall positive increase in 
provider recommendations, overtime, could explain changes in HPV vaccine 
uptake between African American and non-Hispanic Whites.  It should be noted 
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that the increase in provider recommendations is related to a significant portion 
of the positive trend in HPV vaccination among the majority of girls (11). 
Table 3-Logistic Regression Estimates for Males Predicting Provider 
Recommendation, National Immunization Survey-Teen 
 Full Sample 
( n=56.612) 
Hispanic 
(n=7512) 
Black 
(n=5338) 
White 
(n=39,102) 
 Model 1 Model 2 Model 3 Model 4 Model 5 
Year 2.35*** 2.41*** 2.00*** 2.42*** 2.42*** 
Racea      
Hispanic  1.28*** 1.80***    
Black 1.28*** 1.29**    
Other 1.12** 1.11    
Age 0.97*** 0.97*** 0.95* 0.95 0.96*** 
Household Incomeb      
≥75 1.11* 1.11* 1.04 1.23 1.11 
Greater than poverty, 
<75k 0.88** 0.88** 0.91 0.97 0.86* 
Mother’s Educationc      
Less than high school 0.73*** 0.73*** 0.84 0.97 0.64*** 
High School only 0.74*** 0.75*** 0.94 1.01 0.68*** 
Some college 0.79*** 0.79*** 0.93 1.05 0.75*** 
Mother Respondent 1.67*** 1.68*** 1.48*** 1.74*** 1.65*** 
Number of children in 
household 1.22*** 1.22*** 1.17** 1.22** 1.20*** 
Married 0.98 0.98 0.92 0.98 1.02 
Mother’s aged      
35-44 years 0.95 0.94 0.93 1.06 0.96 
≥45 years 0.98 0.98 0.85 1.01 1.01 
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Census Region      
South 0.62*** 0.62*** 0.66*** 0.59*** 0.63*** 
Midwest 0.64*** 0.63*** 0.69*** 0.67*** 0.62*** 
West 0.60*** 0.60*** 0.63*** 0.52*** 0.57*** 
Race Interactions      
Hispanic x Year  0.83***    
Black x Year  1.00    
Other x Year  1.00    
Pseudo R2 0.14 0.14 0.10 0.15 0.15 
Note: 2010-2013 OR odds ratio. Reference categories: a-White (non-Hispanic), 
b-poverty or less, c-college degree, d-less than or equal to 34 yrs, e-Northeast. 
P<0.05*, P<0.01**, P<0.001***. 
Note: Reprinted from Burdette, Amy M., Webb, Noah S., Hill, Terrence D., Jokinen-
Gordon, H. “Race-specific trends in HPV vaccinations and provider recommendations: 
persistent disparities or social progress?” Public Health 142 (2017) p173. 20 June 2018. 
 Table 3 shows that from 2008 to 2013 the odds of provider 
recommendation increase to Black male over 100% (P<0.001).  Compared 
directly to White participants, Black boys had an odds ratio of 1.28 and 1.29 in 
Model 1 and Model 2, respectively, according table 3.  This means that in Model 
1 and Model 2, Black boys were 28% and 29% more likely than White boys to 
have provider recommendation.   
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Table 4-Logistic Regression Estimates for Females Prediction HPV Vaccination 
Uptake, National Immunization Survey-Teen 
 
Full sample 
 (n = 7,389) 
Hispanic  
(n = 
10,188) 
Black 
(n = 
7864) 
White  
(n = 53,019) 
 
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Year 1.12*** 1.10*** 1.04*** 1.19*** 1.20*** 1.10*** 
Racea       
Hispanic 1.26*** 1.05 1.14**    
Black 0.82*** 0.68*** 0.77***    
Other 1.07* 0.99 1.06    
Age 1.17*** 1.17*** 1.18*** 1.08*** 1.10*** 1.20*** 
Household incomeb       
≥75k 1.11*** 1.11*** 0.82*** 0.92 0.95 1.18*** 
Greater than poverty, 
<75k 0.84*** 0.84*** 0.71*** 0.87* 0.93 0.84*** 
Mother’s Educationc       
Less than high school 0.81*** 0.81*** 1.12** 0.76*** 0.96 0.78*** 
High school only 0.85*** 0.85*** 1.03 0.90 0.98 0.81*** 
Some college 0.88*** 0.88*** 0.97 0.87* 1.05 0.85*** 
Mother Respondent 1.36*** 1.36*** 1.03 1.61*** 1.88*** 1.27*** 
Number of Children 
in household 1.00 1.01 0.98 1.13*** 1.09* 0.97* 
Married 0.78*** 0.78*** 0.78*** 0.90* 0.85** 0.76*** 
Mother’s aged       
35-44 years 0.75*** 0.75*** 0.75*** 0.90 0.82** 0.73*** 
≥45 years  0.73*** 0.73*** 0.73*** 0.81** 0.78** 0.71*** 
Census Region*       
South 0.66*** 0.66*** 0.79*** 0.72*** 0.56*** 0.65*** 
Midwest 0.71*** 0.71*** 0.82*** 0.64*** 0.60*** 0.71*** 
West 0.75*** 0.75*** 0.92** 0.82** 0.83 0.71*** 
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Race Interactions       
Hispanic x Year  1.07*** 1.07***    
Black x Year  1.08*** 1.06***    
Other x Year  1.03 1.02    
Provider 
Recommendation 
  8.22***    
Pseudo R2 0.03 0.03 0.17 0.03 0.04 0.03 
Note: 2010-2013 OR=odds ratio. Reference categories: a-White (non-Hispanic), 
b-poverty or less, c-college degree, d-less than or equal to 34 yrs, e-Northeast. P 
< 0.05*, P < 0.01**, P < 0.001***. 
Note: Reprinted from Burdette, Amy M., Webb, Noah S., Hill, Terrence D., Jokinen-
Gordon, H. “Race-specific trends in HPV vaccinations and provider recommendations: 
persistent disparities or social progress?” Public Health 142 (2017) p. 174. 20 June 
2018. 
 Table 4 predicts vaccine uptake in the teenage females of this study. The 
likelihood of vaccine uptake in Black teen females was 20% greater in 2013 
when compared to 2008(P<0.001). This showed that vaccine uptake in Black 
teen females is increasing over time.  There were 3 Models that compared 
likelihood of vaccine uptake in Black females to the likelihood in White females.  
All three showed that the likelihood of vaccine uptake was less when Black 
females were directly compared to White females (P<0.001).   
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Table 5-Logistic Regression Estimates for Males Predicting HPV Vaccination 
Uptake, National Immunization Survey-Teen 
 Full sample 
(n=56,632) 
Hispanic 
(n =7512) 
Black 
(n= 5338) 
White 
(n=39,102) 
 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Year 2.43*** 2.53*** 1.67*** 2.09*** 2.39*** 2.53*** 
Racea       
Hispanic 1.65*** 2.45*** 1.84***    
Black 1.56*** 1.76*** 1.60***    
Other 1.36*** 1.31* 1.25    
Age 1.03** 1.03* 1.08*** 1.01 0.98 1.03* 
Household 
incomeb 
      
≥75k 0.81*** 0.81*** 0.62*** 0.61*** 0.92 0.82** 
Greater than 
poverty, <75k 0.72*** 0.72*** 0.65*** 0.78** 0.91 0.68*** 
Mother’s 
Educationc 
      
Less than high 
school 1.08 1.08 1.61*** 1.15 1.32 0.97 
High school only 0.90* 0.90* 1.14* 1.06 1.22 0.83** 
Some College 0.84*** 0.84*** 0.97 0.94 1.11 0.79***  
Mother 
Respondent 1.33*** 1.33*** 0.90* 1.31* 1.20 1.29*** 
# of children in 
household 1.14*** 1.14*** 1.00 1.18** 1.18** 1.08** 
Married 0.82*** 0.82*** 0.75*** 0.84** 0.85 0.83*** 
Mother’s aged       
35-44 years 0.83*** 0.83*** 0.79*** 0.94 0.92 0.78** 
≥45 years 0.84** 0.84** 0.77*** 0.82 0.85 0.81** 
Census 
Regione 
      
South 0.68*** 0.68*** 0.94 0.81* 0.62*** 0.66*** 
Midwest 0.59*** 0.59*** 0.73 0.65*** 0.66** 0.56*** 
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West 0.64*** 0.64*** 0.89* 0.69*** 0.56** 0.61*** 
Race 
interactions 
      
Hispanic x year 0.82*** 0.96     
Black x Year 0.94 0.98     
Other x Year  1.02 1.06     
Provider 
recommendatio
n 
 35.73***     
Pseudo R2 0.14 0.14 0.43 0.11 0.14 0.14 
Note: 2010-2013; OR=odds ratio. Reference categories: a-White (non-Hispanic), 
b-poverty or less, c-college degree, d-less than or equal to 34 yrs, e-Northeast. 
P < 0.05*, P < 0.01**, P < 0.001***. 
Note: Reprinted from Burdette, Amy M., Webb, Noah S., Hill, Terrence D., Jokinen-
Gordon, H. “Race-specific trends in HPV vaccinations and provider recommendations: 
persistent disparities or social progress?” Public Health 142 (2017) p. 175. 20 June 
2018. 
According to the odds ratio Table 5, Black teenage boys were more likely 
to have vaccine uptake when directly to White teenage boys.  Table 5 also shows 
that Black males in the study were 39% more likely to have vaccine uptake in 
2013 than 2010.  Males overall had an increase in HPV vaccination uptake over 
time (11).  This increase can be related to an overall increase in provider 
recommendation of the vaccine over time.  Among girls, minority teens have 
seen a more drastic increase in provider recommendations and HPV vaccination 
uptake as compared to non-Hispanic White teenage females (11). The previous 
statement is given the fact that, Non-Hispanic White females initially displayed 
higher rates of HPV vaccination in comparison to minority females (11). 
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A cross-sectional, web-based survey was conducted in August 2009, 2 
months before the HPV vaccine was licensed for males by the FDA (13).  A 
randomized intervention study that tested the effect of different male HPV 
vaccination messages on parental views about the vaccine was done (13).  The 
parent sample randomly received one of 2 educational messages (13).  There was 
either a “basic” message about HPV vaccination, or an “expanded” message that 
included information in the basic message plus additional information about the 
benefits of vaccinating males against HPV (13).   The messages are shown in 
Figure 4 below.  Participating parents were then asked a series of questions 
regarding attitudes about male HPV vaccination. 11% of the participants in this 
study were black (13).   Figure 5 below identifies phrases used in this study to 
assess parental attitudes towards vaccination. 
 
Figure 4. The Basic and Expanded Messages(13). 
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Figure 5. Psychological Assessment Phrases(13). 
When analyzing how important parents perceived vaccinating their sons 
against HPV is, 90% of the total parent sample agreed that it was either 
important or very important for males to “get vaccinated against HPV” (13).  It has 
been found that White parents and “other” race parents with higher education, 
parents who had sons, and parents whose sons had no health insurance were 
significantly more likely to believe male HPV vaccination was generally not 
important (13).  Table 6 shows that only 3% of Black participants viewed 
vaccinating their male sons as unimportant (P<0.0001) (13). 
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Table 6-Factors Associated With Believing that Vaccinating Males  
against HPV is Not Important* 
Variable Weighted % Parents Believing Male HPV Vaccination Is Not Important P 
Parent age  0.57 
18-29 8%  
30-44 11%  
45-59 10%  
60+ 16%  
Parental Education  0.0058 
High school 4%  
High school/GED 9%  
Some college 9%  
Bachelor’s Degree or 
higher 15% 
 
Parent race/ ethnicity  <0.0001 
White 12%  
Black 3%  
Other 11%  
Hispanic 6%  
Parent Gender  0.0001 
Male 14%  
Female 7%  
Has Daughters  0.55 
No 10%  
Yes 11%  
Has Sons  0.018 
No 7%  
Yes 11%  
Has young sons (0-8 yr)  0.38 
No 10%  
Yes 11%  
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Has adolescent sons  
(9-17 yr) 
 0.16 
No 9%  
Yes 12%  
Insurance status of 
oldest sonst 
 0.43 
Private 13%  
Public 7%  
Other 12%  
None 18%  
*Among all parents, n =1678. †Among the subsample of parents with boys (n 
=1178). “Oldest son” refers to sons aged 0 to 17 years, currently living in the 
household. 
Note: Reprinted from Dempsey, Amanda F., et al. ”Factors Associated with Parental 
Intentions for Male Human Papillomavirus Vaccination: Results of a National Survey” 
Sexually Transmitted Diseases 38 (2011) p. 773. PMC. Web. 20 June 2018. 
 Among parents of adolescent boys (9–17 years) sampled, but not among 
parents of young boys (0–8 years), higher vaccination intent was also associated 
with having less than a high school education and with black race (Table 7) (13).  
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Table 7-Unadjusted and Adjusted Associations with Parents' Intentions to Have 
Their Son Vaccinated Against HPV 
 Parents of Young 
Boys (0-8 yr) 
Parents of Adolescent 
Boys (9-17 yr) 
Variable Unadjusted Or (95% CI) 
Adjusted 
OR (95% CI) 
Unadjusted 
OR (95% CI) 
Adjusted 
OR (95% CI) 
Parent Education     
High school Ref. Ref. Ref. Ref. 
High School/GED 0.58  (0.17–1.99) 
0.79  
(0.14–4.44) 
00.38  
(0.15–0.94) 
0.20  
(0.06–0.73) 
Some college 0.89  (0.27–2.94) 
0.72  
(0.14–3.77) 
0.36  
(0.14–0.93) 
0.39  
(0.12–1.22) 
Bachelor’s degree 
or higher 
0.69  
(0.21–2.21) 
0.77  
(0.14–3.77) 
0.33  
(0.12–0.84) 
0.49  
(0.15–1.60) 
Parent race/ 
ethnicity 
    
White Ref. Ref. Ref. Ref. 
Black 0.83  (0.30–2.30) 
1.19  
(0.21–6.89) 
3.36  
(1.57–7.19) 
3.18  
(1.22–8.28) 
Other 0.85  (0.36–2.00) 
0.50  
(0.09–2.70) 
1.62  
(0.69–3.75) 
1.39  
(0.39–4.99) 
Hispanic 1.58  (0.87–2.84) 
1.23  
(0.59–2.57) 
0.91  
(0.47–1/76) 
0.81  
(0.25–2.66) 
Parent Gender     
Male Ref Ref. Ref. Ref. 
Female 1.20  (0.76–1.89) 
0.98  
(0.50–1.90) 
1.61  
(1.02–2.54) 
1.85  
(0.95–3.62) 
Son’s Insurance 
Status 
    
Private Ref. Ref. Ref. Ref. 
Public 1.52  (0.84–2.73) 
0.97  
(0.45–6.30) 
1.76  
(0.99–3.12) 
0.47  
(0.20–1.12) 
Other 0.94  (0.38–2.37) 
1.70  
(0.45–6.31) 
1.71  
(0.68–4.33) 
2.84  
(0.76–10.61) 
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None 1.01  (0.31–3/25) 
3.33  
(0.55–20.06) 
0.39  
(0.17–0.93) 
0.62  
(0.20–1.93) 
Perceived Barriers 
score 
0.36  
(0.22–0.59) 
0.17  
(0.09–0.34) 
0.37  
(0.22–0.65) 
0.33  
(0.13–0.82) 
Perceived 
Benefits Score 
15.14  
(6.17–37.12) 
6.78  
(3.18–14.49) 
47.41  
(17.27–130.14) 
17.49  
(6.72–45.52) 
Perceived 
Severity score 
2.58  
(1.61–4.12) 
1.19  
(0.65–2.22) 
3.82  
(2.51–5.83) 
1.39  
(0.83–2.35) 
Perceived 
Susceptibility 
Score 
2.80  
(1.97–3.98) 
1.82  
(1.14–2.91) 
3.58  
(2.54–5.05) 
3.54  
(2.05–6.13) 
Normative 
Influence Score 
10.43  
(6.00–18.12) 
4.56  
(2.10–9.93) 
13.45  
(8.15–22.21) 
4.98  
(2.71–9.14) 
Randomization 
text 
    
Basic Message Ref. Not Included Ref. Ref. 
Expanded 
Message 
1.27  
(0.82–2.00) 
 0.58  
(0.37–0.90) 
0.94  
(0.54–1.66) 
Note: Reprinted from Dempsey, Amanda F., et al. ”Factors Associated With Parental 
Intentions for Male Human Papillomavirus Vaccination: Results of a National Survey” 
Sexually Transmitted Diseases 38 (2011) p. 774. PMC. Web. 20 June 2018. 
Other studies have alluded to the idea that minority race and lower 
education are associated with increased HPV vaccine series initiation but 
decreased vaccine series completion in women (13).  Minorities, people at low 
income levels and people with low levels of education are considered “at risk” (13).  
This is due to the fact that these groups have been shown to be affected by HPV 
related cancers at higher levels (13).  It is important that vaccine distribution reach 
these groups in order to diminish this disparity. 
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Misinformation and lack of education on cervical cancer may contribute to 
currently observed disparities in minority communities, particularly in the African 
American community.  5 lectures at 4 different historically Black colleges in North 
Carolina, Virginia, and West Virginia were completed (14).  The colleges were 
Hampton University, North Carolina Central University, West Virginia University 
and Marshall University.  The lectures were 60 minutes and they reviewed basic 
female anatomy, HPV pathogenesis, cervical dysplasia, cervical cancer, HPV 
vaccination and cervical cancer screening (14).  Participants completed pre- and 
post-lecture surveys assessing knowledge, attitudes and beliefs related to 
cervical cancer screening, HPV, and the HPV vaccine (14).   There were a total of 
72 students who attended the lectures and 57 students completed the surveys 
(14).  96% of the participants were knowledgeable about the HPV vaccine (14).   
Only 52% reported actually receiving the vaccine (14).  42% of the participants 
fully completed the 3-shot series (14).  77% of the students older than 21 years of 
age reported having received a Pap smear (14).  Correct response rates to the 
knowledge-based questions administered significantly increased from 74% to 
91% following with the information intervention (14).   Following the information 
sessions, 94% of the participants confirmed plans to get regular Pap smears and 
87% of the students affirmed plans to actually get the HPV vaccine (14).  
The 51% of the study participants ranged from ages 18 to 20 (14).  46% of 
the participants were 21 years of age or older and 4% of the students 
participating were 17 years of age or less (14). 100% of study participants were 
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African American (14).  49% of participants in the study reported being sexually 
active (14).  Of sexually active group, the most common form of contraception was 
condoms and the birth control pill, with 43% use for each (14).  Of the 21 year old 
participants, 38% were not sexually active at the time of the survey (14).  In the 
group of remaining students who were at least 21 and sexually active, 15% 
reported use of long acting reversible contraceptives, 19% reported condom use, 
11% reported utilizing coitus interruptus or the withdrawal method, and 8% 
reported use of the birth control pill (14).  12% of individuals reported being 
diagnosed with a sexually transmitted infection in the past and at least 1 had 
been exposed to HPV (14).  84% of participating students have heard of Pap 
smear screening (14).  77% of the women of 21 years of age reported ever having 
had a Pap smear (14).  50% of the women who were of age to have a Pap smear, 
yet had not had one are sexually active (14).  96% of the participants reported 
having at least heard about the HPV vaccine prior to this study (14).  54% of the 
participants knew someone who has had the vaccine (14).  53% of the women in 
the study reported at least starting the series and 15% were unsure of their 
vaccination status and 33% had never received the vaccine (14).  42% of all 
participants had all 3 doses (14).  So that contributed to a vaccine series 
completion rate of around 83% (14).  In the never vaccinated population, 20% 
were offered the Gardasil vaccine but declined immunization, 43% were never 
offered the vaccine, and 37% were unsure if they were ever offered. The most 
common reasoning for not having been vaccinated was “My parents did not want 
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me to have this (14)”.  Of the 49% of sexually active participants, the ideal 
percentages for knowledge, vaccine initiation and completion would, of course,  
be 100%.  Unfortunately, this is not the case. It is imperative that Black college 
aged women be HPV informed and vaccinated because they are within the age 
range to receive the vaccine and their sexually activity makes them vulnerable to 
the virus.  Surveying parents’ ideals and attitudes surrounding HPV vaccination is 
important because, as this study shows, it ultimately can have an effect on 
whether a young woman will get vaccinated or not. 
“According to the American Cancer Society's 2017 report of Cancer Facts 
and Figures, the incidence of cervical cancer is still 9.8 per 100,000 in African 
American women, compared to 7.0 per 100,000 in White women, a nearly 40% 
difference”(14).  African American women are more likely than any other 
demographic group to die from cervical cancer (14).  Death rates for African 
American women are 3.8 per 100,000, compared to 2.1 for White Women and 
2.3 for all races combined (14).  The overall 5-year relative survival rate for 
cervical cancer among African American women is 57%, compared to 69% 
among White women (14).  African American women are more likely to be 
diagnosed with cervical cancer at later and more difficult to treat stages (14).  It 
should be noted that according to the National Cancer Database only 53% of 
African American women receive guideline-based care in locally advanced 
cervical cancer (14).  African American women are less likely to receive radical 
hysterectomy for early-stage cervical cancer and are less likely to receive intra-
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cavitary radiation for locally advanced disease (14).  African American women in 
Boston, Massachusetts were interviewed and this survey revealed that 
inadequate information and education of healthcare providers and patients 
created barriers to appropriate screening and treatment practices for African 
American women (14).   
A study was completed to evaluate the impact of increased human 
papillomavirus vaccine availability in Michigan on female patients of Planned 
Parenthood ranging from ages 19 to 26 (3).  Uptake was defined as at least 1 
dose of the 3 vaccine series being received (3). 344 women participated.  21.6% 
of the participants were black (37 women) (3).  None of these Black participants 
were vaccinated at the clinics studied (3).  34 out of the 37 Black participants in 
the study remained unvaccinated at the end of the study (3).  Black women 
accounted for 23.8% of all participants who remained unvaccinated even after a 
pointed increase in the availability of the HPV vaccine in their area (3).  Availability 
is likely not the only factor that affects uptake of the human papillomavirus 
vaccine in the Black community. As increasing the vaccine availability did nothing 
to increase uptake in this study. 
  In a mixed mode survey done in Alabama, 280 African American mothers 
and their adolescent daughters from the community were analyzed (15).  This 
study was inspired by the fact that African American women have the highest 
rates of cervical cancer when compared to other races (15).  Yet, Gardisil-9, which 
is highly effective for preventing cervical cancer, use is 60.5% for initiation and 
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33.4% for completion (15).  Items examined by this survey were: likelihood of the 
parent to comply with doctor recommendation,  socio-demographics, experience 
with HPV, most trusted information source, type of information received, HPV 
knowledge, culture and Health Belief Model constructs (which are: Perceived 
susceptibility, severity, benefits and barriers) (15).  It should be noted that he 
Health Belief model is a method of determining why individuals engage in 
preventable behaviors (15).  Table 8 below presents the demographics and 
background characteristics of the women and adolescents studied. 
Table 8-Demographic and Background Characteristics 
Characteristics N % 
Mother’s Age   
19-29 17 7.2 
30-39 125 52.7 
40-49 73 30.8 
50+ 22 9.3 
Education   
GED/High School (or less) 61 25.7 
Some College (1-3 years) 80 33.8 
College (4+ years)/ Post-Graduate 96 40.5 
Household Income   
<$20,000 71 30.0 
$20,000-$40,000 63 26.6 
$40,001-$60,000 59 24.9 
$60,000+ 44 18.6 
Medical insurance of Daughter   
Medicaid/All Kids 123 50.2 
Health Insurance through Guardian 110 46.4 
Other 3 1.3 
Daughter’s Age   
9 years 62 26.2 
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10 years 61 25.7 
11 years 52 21.9 
12 years 62 26.2 
Personal Experience with HPV (or 
related conditions)   
Yes 87 36.7 
No/ I Don’t Know 150 63.3 
Type of Information Received on the 
HPV vaccine   
Mostly Positive 103 43.5 
Positive and Negative/Mostly Negative 90 38.0 
Haven’t Heard Anything 44 18.6 
Most Trusted Source of Information   
Physician 193 81.4 
Other (e.g., family, religious leader, 
media sources, friends, school staff) 33 13.9 
Haven’t heard anything 11 4.6 
Note: Reprinted from Cunningham-Erves, Jennifer L., et al. “A Physician’s 
Recommendation for HPV Vaccination: What Makes African American Mothers 
Compliant?” The Pediatric Infectious Disease Journal Publish Ahead of Print. PMC. 
Web. 13 June 2018.  
   Most of the mothers in this study had the intention of vaccinating their 
daughters, especially once they had been informed of the benefits of the vaccine.  
The more perceived advantages to disadvantages, the greater the likelihood of 
the mother agreeing to vaccinate her daughter (15).  According to Table 8, 193 
mothers or 81.3% of the mothers trusted their physician as a reliable source of 
information about the HPV vaccine. Table 9 shows that mothers were more likely 
to have heard about the HPV vaccine from a physician than to have not heard 
anything at all.  Black mothers were also more likely to have heard positive 
information about the HPV vaccine according to Table 9.  The reason for concern 
 36 
for most of the mothers in this study was there perception of the risk that the HPV 
vaccine on their daughters’ health (15).  This study showed that the ultimate goal 
of the African American mother in this population is to protect her daughter (15).  
The greater the perceived advantage and the lower the perceived disadvantage 
of the vaccine by the mother, greater the likelihood of vaccine administration to 
the adolescent (15).  The statistics in Table 9 show that African American mothers 
were not likely to perceive barriers to vaccinating their daughter.  African 
American mothers were extremely likely to perceive the HPV vaccine as 
beneficial.  Mothers were 57% likely to perceive their daughters susceptible to 
the negative effects of HPV without the virus.  Mothers were only 4% likely to 
perceive HPV as severe. 
Table 9-Logistic Regression of Associations with Mother's Likelihood  
of Acceptance of a Physicians Recommendation to get  
Daughter Vaccinated for HPV 
 
Predictor OR SE CI P-value 
Type of Information     
Haven’t heard anything Ref    
Positive & Negative/Mostly Negative 2.09 0.56 [0.70, 6.29] 0.188 
Mostly Positive 0.97 0.49 [0.37, 2.53] 0.952 
Most Trusted Source of Information 
for HPV vaccine     
Haven’t  heard anything Ref    
Other 0.51 0.83 [0.10, 2.56] 0.412 
Physician 2.91 0.72 [0.71, 12.00] 0.140 
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Attitudes     
Perceived Barriers 0.37 0.37 [0.18, 0.77] 0.007** 
Perceived Benefits 2.55 0.31 [1.39, 4.68] 0.002** 
Perceived Susceptibility 1.57 0.23 [1.01, 2.46] 0.047* 
Perceived Severity 1.04 0.22 [0.68, 1.61] 0.846 
Culture: Future Time Orientation 0.27 0.40 [0.13, 0.60] 0.001** 
Note: **Variable is significant at the .01 level. *Variable is significant at the .05 
level.  
Note: Reprinted from Cunningham-Erves, Jennifer L., et al. “A Physician’s 
Recommendation for HPV Vaccination: What Makes African American Mothers 
Compliant?” The Pediatric Infectious Disease Journal Publish Ahead of Print. PMC. 
Web. 13 June 2018.  
Women living in rural areas in the Southern United States have higher 
rates of cervical cancer related deaths than women living in urban areas (16).  A 
study analyzed a rural community of women (16).  A rural area is considered an 
area with fewer than 200 persons per square mile (16).  The study was done in 
Person County, North Carolina on Black and White women (16). This study was 
conducted to discover whether there is a difference in knowledge and attitudes 
about HPV between the two races (16).  Person County has one of the highest 
cervical cancer mortality rates in the U.S. at 5.8 deaths per 100,000 women. (16) 
Study participants were recruited from public health clinic and OB/GYN office 
waiting rooms and paid upon study completion (16). Awareness of HPV and 
knowledge of HPV, perception of severity and likelihood of HPV infection was 
assessed via questionnaire (16).  Perceived likelihood and severity of cervical 
cancer were surveyed (16).  Awareness and perception of the HPV vaccination 
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were assessed as well (16).  Of the 138 women studied, 91 were Black and 47 
were White.  The mean age was 42 and the age range was 18-84 (16).  85% of 
the women were parents and 20% had daughters ages 11-17 (16).  80% had a 
high school education or higher (16).  77 % had some form of insurance and 28% 
reported difficulty paying their bills (16).  Black participants were more highly 
recruited from the public clinic (16).  24% of Black women had heard of HPV 
compared to 57% of White women (16).  Black women had less HPV knowledge, 
getting 29% of the questions about HPV asked correct versus their counterparts 
who got 42% correct (16).  Black participants were also less likely to view HPV 
infection as a serious threat to themselves or their daughters (16).  59% of the 
Black participants felt that they had a chance of getting cervical cancer versus 
79% of White participants (16).  Black women were also less likely to see cervical 
cancer as a threat to their own health or their daughter’s health (16).  Black 
women were less likely to view diagnosis with cervical cancer as having negative 
consequences (16).  A greater amount of Black women perceived the 
effectiveness of the HPV vaccine against cervical cancer than White women (16).  
63% of the Black women felt that the appropriate age for HPV vaccine 
administration was 17 years or older while 60% of White women felt the 
appropriate age for vaccination was younger than 17 years (16).  Black women 
also had lower intentions to vaccinate themselves or their daughters (16).  The 
study shows that Black women in rural areas are less informed about human 
papillomavirus and less likely to understand the importance of getting vaccinated 
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against the virus.  This means they are less likely to initiate and complete the 
vaccine series and are ultimately more likely to have HPV-related cancer 
diagnosis.  Below, table 10 displays the statistics of produced by the study done 
on southern rural women. 
Table 10-Awareness and Attitudes about HPV infection, Cervical Cancer, 
Vaccines and the HPV Vaccine 
 
Blacks 
(n=91) 
% 
Whites 
(n=47) 
% 
Unadjusted 
Odds Ratio  
(95% CI) 
Adjusted Odds 
Ratio (95% CI) 
HPV Infection     
Awareness of HPV 24 57 0.23  (0.11-0.50)*** 
0.21  
(0.09-0.49)*** 
Any chance of getting HPVa 54 53 1.06 (0.52-2.16) 1.18 (0.54-2.55) 
Perceived severity of HPVb 71 91 0.23 (0.08-0.71)* 0.23 (0.07-0.72)* 
Any chance that daughter 
will get HPVa 78 91 0.33 (0.11-1.03) 0.36 (0.11-1.16) 
Perceived severity of 
daughter’s HPVb 70 91 0.22 (0.07-0.68)** 0.24 (0.07-0.76)* 
Cervical Cancer     
Any chance of getting 
cervical cancera 59 79 0.40 (0.18-0.89)* 0.42 (0.17-1.01) 
Perceived severity of 
cervical cancerb 92 98 0.26 (0.03-2.19) 0.30 (0.03-2.57) 
Any chance that daughter 
will get cervical cancera 81 85 0.76 (0.30-1.99) 0.82 (0.30-2.28) 
Perceived severity of 
daughter’s cervical cancerb 75 96 0.13 (0.03-0.59)** 0.10 (0.02-0.47)** 
HPV vaccine      
Awareness of HPV vaccine 20 21 0.91 (0.38-2.17) 0.92 (0.33-2.57) 
Perceived effectiveness 
against HPVc 44 28 1.99 (0.93-4.27) 2.03 (0.91-4.57) 
Perceived effectiveness 
against cervical cancerc 52 34 2.05 (0.98-4.27) 2.59 (1.14-5.89)* 
High safetyd 41 26 2.12 (0.97-4.62) 1.88 (0.82-4.35) 
Serious side effectsd 44 28 1.99 (0.93-4.27) 2.03 (0.91-4.57) 
Best age to vaccinate 17 
years or oldere 63 40 2.47 (1.20-5.08)* 2.85 (1.30-6.26)** 
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 Means (SD) 
Means 
(SD) 
Unadjusted 
Differences (95% 
CI) 
Adjusted 
Differences 
(95% CI) 
HPV infection     
HPV knowledge 29% (0.22) 
42% 
(0.28) 
−0.12  
(−0.22 to −0.04)** 
−0.1  
(−0.19 to −0.01)* 
Cervical Cancer     
Cervical cancer has 
negative consequencesf 
6.7 
(2.4) 
7.5 
(1.7) 
−0.86  
(−1.64 to −0.08)* 
−0.86  
(−1.69 to −0.04)* 
Cervical cancer is treatablef 6.3 (2.8) 
6.7 
(2.1) 
−0.42  
(−1.34 to 0.51) 
−0.30  
(−1.26 to 0.65) 
Cervical cancer is well 
understoodf 
6.7 
(3.5) 
6.1 
(3.4) 
0.60  
(−0.63 to 1.84) 
0.40  
(−0.94 to 1.74) 
HPV vaccine     
Vaccines (in general) are 
beneficialg 
4.1 
(1.1) 
4.5 
(0.6) 
−0.40  
(−0.74 to −0.07)* 
−0.44  
(−0.80 to −0.08)* 
Vaccines (in general) are 
unnecessaryg 
2.9 
(0.9) 
2.5 
(0.7) 
0.34  
(0.04 to 0.63)* 
0.37  
(0.06 to 0.68)* 
HPV vaccines are beneficialg 3.3 (0.9) 
3.3 
(0.7) 
0.08  
(−0.22 to 0.38) 
0.08  
(−0.24 to 0.40) 
HPV vaccines are good for 
adolescentsg 
3.4 
(1.2) 
3.8 
(0.9) 
−0.33  
(−0.72 to 0.06) 
−0.26  
(−0.67 to 0.15) 
Cues to action to vaccinate 
daughterh 
4.8 
(1.0) 
4.3 
(0.7) 
−0.04  
(−0.36 to 0.29) 
0.01  
(−0.31 to 0.34) 
Low perceived barriers to 
vaccinating daughterh 
4.3 
(0.9) 
4.4 
(0.6) 
−0.11  
(−0.41 to 0.18) 
−0.09  
(−0.39 to 0.21) 
Intention to vaccinate selfi 3.6 (1.4) 
4.1 
(1.3) 
−0.53  
(−1.01 to −0.05)* 
−0.32  
(−0.79 to 0.16) 
Willingness to pay for own 
vaccinej 
4.1 
(2.5) 
4.5 
(2.7) 
−0.44  
(−1.37 to 0.49) 
−0.31  
(−1.27 to 0.66) 
Intention to vaccinate 
daughteri 
4.1 
(1.2) 
4.6 
(0.8) 
−0.41  
(−0.78 to −.04)* 
−0.29  
(−0.68 to 0.10) 
Willingness to pay for 
daughter’s vaccinej 
4.9 
(2.3) 
5.1 
(2.4) 
−0.20  
(−1.04 to 0.64) 
0.02  
(−0.86 to 0.90) 
Note: Adjusted analyses controlled for age, socioeconomic status, and clinic location 
but not other variables in the table. HPV = human 
papillomavirus. The reference group in logistic regressions was white respondents. 
Single item attitude variables with 6 or fewer 
response scale options were dichotomized as indicated in table footnotes. Linear 
regression analyses of the variables before they were 
dichotomized found “any chance of getting cervical cancer” and “best age to vaccinate” 
not statistically significant while “any chance 
that daughter will get HPV” became statistically significant. Multi-item scales and 
questions with 8 to 11 point response scales were 
treated as continuous variables. 
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***P < .001, **P < .01, *P < .05. 
a5-point scale recoded such that 0 = no chance and 1 = low, moderate, high chance 
and certain. 
b6-point scale recoded such that 0 = no threat, very low and low threat 1 = moderate, 
high and very high. 
c5-point scale recoded such that 0 = not at all, slightly, moderately and 1 = very and 
extremely. 
d5-point scale recoded such that 0 = strongly disagree, slightly disagree, neither agree 
nor disagree and 1 = slightly and strongly agree. 
e5-point scale recoded such that 0 = (0-2, 3-10, 11-16 years) and 1 = (17-25, 25+). 
f11-point scale (no effect to severely affects my life). 
g5-point scale (strongly disagree to strongly agree). 
h5-point scale (discourage a lot to encourage a lot). 
I5-point scale (very unlikely to very likely). 
j8-point scale (nothing to $400+). 
Note: Reprinted from Cates, Joan R., et al. “Racial Differences in HPV Knowledge, HPV 
Vaccine Acceptability, and Related Beliefs Among Rural, Southern Women.” The 
Journal of Rural Health. (2009) p. 95. PMC. Web. 18 July 2018. 
Acceptance of the HPV vaccine may be lower in some religious 
communities due to the correlation of the transmission of any sexually 
transmitted infection to early or premarital sexual activity.  It has been found that 
approximately 53% of African American adults report attending weekly religious 
service compared to 39% of the overall American population (17).  The African 
American church tends to be a major part of many African American 
communities.  This connection provides reason to investigate the African 
American church attending population and their attitude and knowledge of HPV 
further.  This is an interesting effort to understand vaccination attitudes in the 
Black community.  Data was gathered from a Baptist church in Houston, Texas 
using a convenience sampling method in a computerized questionnaire format 
(17).  Participants were paid for completing the study (17).  The sample comprised 
308 African American women (17).  Their HPV awareness, knowledge concerning 
 42 
HPV transmission, knowledge concerning HPV related cancer and attitude 
regarding HPV vaccination was assessed (17).  Participants ranged from 18-83 
years of age (17).  62% of participants had heard of HPV (17).  Greater awareness 
of HPV was linked to younger age, greater education and the presence of minors 
in the household (17).  17.8% of the total participants knew that oral HPV could be 
transmitted via deep kissing (17).  Lower education, lower income and 
unemployment were associated with knowledge about the transmission of HPV 
via deep kissing (17).  58.6% of the total respondents knew that HPV and cervical 
cancer were associated (17).  11.3% of those surveyed knew HPV can cause 
oropharyngeal cancers and 4% of the participants knew that HPV caused penile 
and anal cancers, as well (17).  66.4% of the women surveyed felt that girls and 
boys should both receive the HPV vaccine (17).  14.6% of the respondents 
believed the HPV vaccine should only be given to girls (17).  4.7% of the 
participants believed that the vaccine should not be given to either boys or girls 
(17).  33.3% of participants would vaccinate a daughter as young as 9 or 10 years 
old against HPV and 31.4% would vaccinate sons of the same age (17). Younger 
age correlated to greater intention to vaccinate younger daughters (17).  Intention 
to vaccinate sons followed the same phenomenon (17).  74.4% of the respondents 
understood that HPV was related to 1 of the 4 cancers suggested in the survey 
(17).  2.4% knew that HPV was connected to 2 cancers (17).  0.7% knew HPV 
caused 3 cancers and 2.8% knew that HPV was connected to all 4 cancers 
stated in the survey (17).  13.2% of the study participants knew that HPV was 
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related to non-cervical cancers (17).  19.7% of those studied responded that they 
had no knowledge that the HPV was associated with cancer (17).  There was 
positive correlation found between intent to vaccinate a child ages 9-10 and 
knowledge of the number of cancers connected to HPV (17).  Knowledge that HPV 
is related to non-cervical cancers correlated to a greater intent to vaccinate 
young girl and boys with the larger intent percentage being for boys (17).  47.5% 
of respondents with knowledge of HPV’s relation to non-cervical cancers would 
vaccinate a hypothetical son while 28.2% of respondents, who were not 
educated on the positive correlation of HPV to non-cervical cancers, would 
vaccinate a son (17).  While religion is a strong factor that affects the likelihood of 
vaccine uptake, knowledge about HPV seems to outweigh religious beliefs in 
those studied. 
 A National Health Interview Survey was conducted by the National Center 
for Health Statistics (12).  34,557 participants under 26 years of age were 
observed (12).  The study examined HPV vaccine initiation against different 
economic, demographic and health care variables (12).  This study found that 
African Americans were had lower initiation rates compared to the reference 
group of White Americans (12).  The results and statistics and interactions of these 
demographics are displayed in tables 11, 12 and 13 below.  
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Table 11-Descriptive Statistics -NHIS 2013 Adult Sample of age 18-26 years 
 American-born Foreign-born 
 All Male Female All Male Female 
 (1) (2) (3) (4) (5) (6) 
 Panel A: demographic distribution 
White, % 77.4  (0.75-0.79) 
78.9 
(0.77-0.81) 
76.1 
(0.74-0.78) 
60.5 
(0.56-0.65) 
60.4 
(0.54-0.67) 
60.5  
(0.54-0.67) 
African 
American, % 
15.5  
(0.14-0.17) 
13.7 
(0.12-0.16) 
17.1 
(0.15-0.19) 
11.2 
(0.08-0.14) 
10.8 
(0.07-0.15) 
11.6  
(0.07-0.16) 
Asian, % 2.8  (0.02-0.03) 
3.1 
(0.02-0.04) 
2.6  
(0.02-0.03) 
24.8 
(0.21-0.29) 
25.4 
(0.19-0.31) 
24.2  
(0.19-0.30) 
All other 
race, % 
4.2  
(0.04-0.05) 
4.3 
(0.03-0.05) 
4.1  
(0.03-0.05) 
3.5 
(0.02-0.05) 
3.3 
(0.02-0.05) 
3.7  
(0.00-0.07) 
 Panel B: differences in means (percentages) across nativity and sex 
HPV ever, % 27.1  (0.25-0.29) 
8.5 
(0.07-0.10) 
44.9 
(0.41-0.49) 
17.2 
(0.12-0.22) 
6.4 
(0.02-0.11) 
30.1  
(0.22-0.38) 
Married, % 12.9  (0.11-0.15) 
11.8 
(0.09-0.14) 
14.0  
(0.12-0.16) 
19.4 
(0.15-0.24) 
16.5 
(0.11-0.22) 
22.7 
(0.14-0.31) 
No 
insurance, % 
20.4  
(0.19-0.22) 
23.6 
(0.21-0.27) 
17.4 
(0.15-0.20) 
39.8 
(0.34-0.46) 
45.9 
(0.38-0.54) 
32.6 
(0.23-0.42) 
No usual 
place of 
care, % 
27.0  
(0.25-0.29) 
32.7 
(0.29-0.36) 
21.5 
(0.19-0.24) 
43.1 
(0.36-0.50) 
55.1 
(0.46-0.64) 
28.7 
(0.20-0.38) 
High income, 
% 
9.0  
(0.08-0.10) 
13.1 
(0.11-0.16) 
5.1 
(0.04-0.06) 
6.6 
(0.03-0.10) 
7.0 
(0.03-0.11) 
6.0 
(0.00-0.12) 
College 
graduate, % 
23.5  
(0.21-0.26) 
21.6 
(0.18-0.25) 
25.3 
(0.22-0.28) 
30.5 
(0.24-0.37) 
26.8 
(0.19-0.35) 
34.9 
(0.25-0.45) 
All cells report percentages, 95% confidence interval (CI) are in brackets 
Note: Reprinted from De, P., Budhwani, H., “Human papillomavirus (HPV) vaccine 
initiation in minority Americans.” Public Health 144 (2017) p. 88. PMC. Web. 17 July 
2018. 
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Table 12-Logistic Regression of HPV Vaccination on Race, Foreign-born Status, 
Economic and Healthcare Access Variables-NHIS 2013 
Variables Baseline model Full model Interaction 
 (1) (2) (3) 
Race (reference group: white)    
African American 0.643*** (0.495-0.836) 
0.742* 
(0.533-1.032) 
0.742* 
(0.533-1.33) 
Asian 0.901 (0.577-1.407) 
0.993 
(0.585-1.687) 
0.994 
(0.585-1.687) 
All other 0.880 (0.595-1.300) 
1.149 
(0.670-1.970) 
1.148 
(0.670-1.970) 
Age 0.892*** (0.856-0.930) 
0.823*** 
(0.778-0.871) 
0.823*** 
(0.778-0.871) 
Male 0.130*** (0.105-0.161) 
0.118*** 
(0.0907-0.153) 
0.118*** 
(0.0908-0.153) 
Married 0.638*** (0.488-0.833) 
0.824 
(0.588-1.154) 
0.824 
(0.588-1.154) 
Foreign born 0.480*** (0.341-0.675) 
0.620** 
(0.398-0.966) 
0.617** 
(0.390-0.975) 
High income  0.923 (0.524-1.628) 
0.918 
(0.499-1.688) 
College Graduate  1.838*** (1.356-2.491) 
1.838** 
(1.356-2.492) 
No Insurance  0.573** (0.424-0.775) 
0.573*** 
(0.424-0.775) 
No Usual Place of care  0.679** (0.503-0.917) 
0.679** 
(0.503-0.917) 
High income*   1.066 (0.196-5.813) 
Foreign born   1.066 (0.196-5.813) 
Observations 34,219 32,462 32,462 
Cells report odds ratios. 95% confidence intervals (CI) are in brackets. ***0.01, **<0.05, 
*<0.1.  All variables except age are categorical variables 
Note: Reprinted from De, P., Budhwani, H., “Human papillomavirus (HPV) vaccine 
initiation in minority Americans.” Public Health 144 (2017) p. 89. PMC. Web. 17 July 
2018.  
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Table 13-Logistic Regression of HPV Vaccination on Race, Foreign-born Status, 
Economic and Healthcare Access Variables by Sex- NHIS 2013 
Variables Male Female 
 (1) (2) 
Race(reference group: 
white) 
  
African American 0.852 (0.405-1.794) 0.653** (0.459-0.928) 
Asian 1.397 (0.658-2.962) 1.006 (0.499-2.027) 
All other 0.554 (0.117-2.609) 1.414 (0.727-2.751) 
Married 0.485* (0.218-1.080) 0.593*** (0.412-0.853) 
Foreign Born 0.901 (0.428-1.896) 0.574** (0.354-0.930) 
High Income 1.312 (0.625-2.755) 0.549* (0.288-1.046) 
College Graduate 0.654 (0.320-1.336) 1.479** (1.060-2.063) 
No insurance 0.336** (0.143-0.791) 0.586*** (0.417-0.823) 
No usual place of care 0.956 (0.551-1.658) 0.556*** (0.393-0.785) 
Observations 31,735 32,200 
Cells report odds ratios.  95% Confidence intervals (CI) are in brackets. 
***P<0.01, **<0.05, *P<0.1. White is the reference group for race.  All variables 
except age are categorical variables. 
Note: Reprinted from De, P., Budhwani, H., “Human papillomavirus (HPV) vaccine 
initiation in minority Americans.” Public Health 144 (2017) p89. PMC. Web. 17 July 2018. 
Table 12 shows that African Americans were less likely to vaccinate 
against HPV when using White Americans as a reference in both the baseline 
and full model analysis.  Table 13 shows that male African Americans were about 
15% less likely to vaccinate than White American males.  Table 13 also shows 
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that female African Americans were around 35% less likely to vaccinate when 
compared directly to White American females (P<0.05). 
There are multiple vaccines approved and available for public use to 
protect against the contraction of HPV.  However, statistics across multiple 
studies show disparities in HPV vaccine uptake across African American 
communities and communities of African descent (i.e., communities not located 
in the Americas populated with people of direct African descent) (12). When 
examining knowledge surrounding HPV and the vaccine from a bivalent race 
stand point Black people were found to be 89% informed and White people were 
found to be 97% informed (10).  On average, young black women were less likely 
to initiate the HPV vaccine series than were young white women (8). It is 
important to understand the reasoning behind this knowledge gap in order to be 
able to develop interventions.   
A cross-sectional survey of 555 African Americans and Afro-Caribbeans 
residing in the US and the Bahamas was done to compare both the knowledge 
and attitudes that African Americans and Afro-Caribbeans have towards the 
human papillomavirus and its prophylactic vaccine (10).  The survey was done on 
the general population of three urban northeastern cities that varied in size and 
demographics (10).  The questionnaire used in this study contained demographic 
questions related to age, race, sex, place of birth, religion, income, education, 
health insurance status, parental status and number of children (10).  The study 
instrument used to provide participants with information on human papillomavirus 
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contained measures of HPV knowledge and safety, efficacy, and the impact of 
the HPV vaccine (10).  75% of the survey participants were female and 25% were 
male (10).  The majority of participants were between the ages of 18 and 35 (10).  
US participants were more likely to have attended college in this study and a 
larger percentage of the US population was single compared to the Bahamian 
population (10).  Income varied between the US and Bahamian population as   
well (10).  Table 14 elucidates the demographic information of the study. 
Table 14-Description of Study Population 
 
US Black 
Participants (%) 
West Indian 
participants (%) 
𝑃 value 
Age (years) 
18-35 
36-55 
56+ 
n= 226 
182 (80.5) 
38 (16.8) 
6 (2.7) 
n= 325 
160 (49.2) 
139 (42.8) 
26 (8)  
< 0.0001 
Gender 
Female 
Male 
n= 226 
62 (27.4) 
164 (72.6) 
n=323 
78 (24.1) 
245 (75.9) 
0.385 
Education 
< High School 
High School 
Some College 
College 
Graduate School 
n=226 
0 (0.0) 
23 (10.2) 
125 (55.3) 
62 (27.4) 
16 (7.1) 
n=323 
37 (11.5) 
101 (31.3) 
58 (17.9) 
71 (22.0) 
56 (17.3) 
<0.0001 
Marital Status 
Married 
Single 
Other 
n= 227 
23 (10.1) 
192 (84.6) 
12 (5.3) 
n= 328 
108 (32.9) 
137 (41.8) 
83 (25.3) 
<0.0001 
Parent 
Yes 
No 
n= 213 
51 (23.9) 
162 (76.1) 
n= 287 
187 (65.2) 
100 (34.8) 
<0.0001 
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Income 
<US$ 15,000 
US$15,000–US$25,000 
US$25,000–US$35,000 
US$35,000–US$45,000 
US$45,000–US$55,000 
Above US$55,000 
n= 204 
49 (24.0) 
24(11.8) 
17 (8.3) 
18 (8.8) 
13 (6.4) 
83 (40.7) 
n= 264 
61 (23.1) 
77(29.2) 
54 (20.5) 
20 (7.6) 
21 (7.9) 
31 (11.7) 
<0.0001 
Health Insurance Status 
Uninsured  
Insured  
n= 221 
15 (6.8) 
206 (93.2) 
n= 315 
167 (53.0) 
148 (47.0) 
<0.0001 
Note: Blackman, Elizabeth et al. “Multicenter Study of Human Papillomavirus and the 
Human Papillomavirus Vaccine: Knowledge and Attitudes among People of African 
Descent.” Infectious Diseases in Obstetrics and Gynecology 2013 (2013): 428582 p3. 
PMC. Web. 20 June 2018. 
Bahamian participants were less aware of the virus than US participants 
with 89% US participant awareness versus 61.5% Bahamian participant (10). This 
statistic remained consistent for 6 out of the 10 questions testing the human 
papillomavirus knowledge of the participants (10).  Most participants understood 
that HPV could lead to cervical cancer in women, lower percentages of both 
groups of respondents understood that genital warts were caused by human 
papillomavirus and that genital warts and cervical cancer were caused by 
different strains of human papillomavirus(10).  Table 15 from the study provides 
statistical insight into how knowledgeable the participants were on the virus itself. 
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Table 15-HPV Knowledge.  Adjusted for Age, Level of Education, Marital Status, 
Parental Status, Health Insurance Status, and Income Level 
 US 
% (95%CI) 
Bahamas 
% (95%CI) 
𝑃 
value 
Have you heard of the human 
papillomavirus (HPV)? Answer = yes 
89.5 
(82.4–93.9) 
61.5 
(52.3–69.9) 0.000 
HPV is not a sexually transmitted 
disease. Answer = false 
51.5 
(42.3–60.7) 
31.4 
(24.6–39.2) 0.002 
HPV is a relatively uncommon disease. 
Answer = false 
69.2 
(60.3–76.9) 
40.6 
(33.0–48.7) 0.000 
HPV causes cervical cancer.  
Answer = true 
69.8 
(60.1–77.7) 
53.9 
(45.5–62.0) 0.019 
Who can become infected with HPV? 
Answer = both men and women 
42.5 
(34.0–51.5) 
31.5 
(24.8–39.0) 0.076 
Both men and women can have cervical 
cancer. Answer = false 
69.1 
(60.2–76.7) 
64.9 
(56.9–72.1) 0.512 
The incidence of HPV in women is 
highest among women in their 20s and 
30s.  Answer = true 
56.3 
(46.9–65.3) 
29.2 
(22.4–36.9) 0.000 
Most people with genital HPV infections 
are symptomatic. Answer = no 
35.5 
(27.3–44.6) 
20.7 
(15.1–27.6) 0.009 
HPV causes genital warts.  
Answer = true 
28.2 
(21.1–36.6) 
33.2 
(26.1–41.1) 0.400 
Genital warts are caused by the same 
HPV types that cause cervical cancer. 
Answer = false 
13.8 
(8.8–20.9) 
7.5 
(4.5–12.4) 0.066 
There is a cure for HPV infection. 
Answer = no 
37.2 
(28.6–46.6) 
22.6 
(16.6–30.0) 0.013 
Note: Blackman, Elizabeth et al. “Multicenter Study of Human Papillomavirus and the 
Human Papillomavirus Vaccine: Knowledge and Attitudes among People of African 
Descent.” Infectious Diseases in Obstetrics and Gynecology 2013 (2013): 428582  p. 4. 
PMC. Web. 20 June 2018. 
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Table 16-HPV Vaccine Knowledge. Adjusted for age, Level of education, Marital 
Status, Parental Status, Health Insurance Status, and Income Level 
 
US 
% (95%CI) 
Bahamas 
% (95%CI) 
𝑃 
value 
Have you heard about the HPV 
vaccine? Answer = yes 
66.9 
(57.3–75.3) 
50.6 
(42.0–59.1) 
0.021 
Who is eligible for the HPV vaccine? 
Answer = women* 
51.0 
(42.2–59.7) 
35.2 
(28.4–42.7) 
0.013 
For which age group is the HPV vaccine 
recommended?  
Answer = 9 through 26 
47.6 
(38.9–56.6) 
40.4 
(33.0–48.2) 
0.264 
Once vaccinated, women no longer 
have to be screened (annual Pap 
smears) for cervical cancer.  
Answer = false 
75.3 
(66.9–82.1) 
51.5 
(43.6–59.4) 
0.000 
*At the time the survey was administered, no HPV vaccine was FDA approved 
to be administered 
Note: Blackman, Elizabeth et al. “Multicenter Study of Human Papillomavirus and the 
Human Papillomavirus Vaccine: Knowledge and Attitudes among People of African 
Descent.” Infectious Diseases in Obstetrics and Gynecology 2013 (2013): 428582 p4. 
PMC. Web. 20 June 2018. 
 Table 16 shows statistical information pertaining to the vaccine knowledge 
that participants had.  Most participants had heard about the vaccine and a larger 
amount of US participants knew about the vaccine (10).  It is important to note that 
at the time that this survey was administered, the HPV vaccine had not yet been 
approved for male use (10).  This is likely to have affected the responses of males 
when answering questions assessing their knowledge of the vaccine.  When 
assessed on their knowledge of the human papillomavirus, Bahamians were 
more likely to answer incorrectly than African Americans assessed (10).  For U.S. 
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participants surveyed, HPV vaccine awareness was first provided via 
advertisement and then by a health professional, the news, and school (10).  For 
Bahamian participants, HPV vaccine awareness was provided first by 
advertisement and then by a healthcare professional with less contribution from 
any other sources (10).  Figure 6 provides an illustration of where Bahamian and 
US participants received their information about the human papillomavirus 
vaccine.  Table 17 provides a comprehensive view of the answers provided by 
participants.     
Table 17- Correct Answers to Overall HPV and Vaccination Knowledge 
Questions 
Number of correct answers US participants 𝑛 = 227 Caribbean participants 𝑛 = 328  
0-1 14 (6.2) 152 (46.3) <0.0001 
2–7 64 (28.2) 85 (25.9) 
 
8–11 92 (40.5) 52 (15.9) 
 
12 or more 57 (25.1) 39 (11.9) 
 
Note:  Blackman, Elizabeth et al. “Multicenter Study of Human Papillomavirus and the 
Human Papillomavirus Vaccine: Knowledge and Attitudes among People of African 
Descent.” Infectious Diseases in Obstetrics and Gynecology 2013 (2013): 428582 p5. 
PMC. Web. 20 June 2018. 
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Figure 6. HPV Vaccine Knowledge: Where Did You Learn About The HPV Vaccine? 
Distribution of those who heard of the HPV vaccine by the source of knowledge, 
stratified by geographic location(10). 
When asked whether or not the HPV vaccine should be given to both boys 
and girls, in both groups, most participants agreed that both genders should 
receive the vaccine (Figure 7).   For both US and Bahamian parents, the majority 
indicated that they were willing to vaccinate their daughters (US = 21/51, 41% 
and Bahamas= 96/187, 51%).  Most of the 51% of US parents unwilling to 
vaccinate their daughters, reported that it was due to safety concern.  66% of the 
41% of Bahamian parents who were unwilling to vaccinate their daughters did 
not indicate a reason.  In both populations, 90% or more respondents agreed that 
they still needed assurance of the vaccines safety and efficacy.  The majority of 
participants from both populations did not feel that administration of the vaccine 
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would encourage risky sexual behavior and felt that discussing issues of 
sexuality before vaccination was necessary.  When asked if an informed child 
should be able to request vaccination at sexual health clinics without parental 
consent, almost 80% of Bahamian respondents felt that children should not be 
able to receive the vaccine without parental consent compared to 57% of 
American respondents 
 
Figure 7. Attitudes towards HPV vaccination. Responses to questions that evaluated 
attitudes towards HPV vaccination, stratified by geographic location(10). 
 
 This study displays that there are disparities between different groups of 
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people of African descent.  African Americans surveyed generally had more 
knowledge about the human papillomavirus and its vaccine (10).  This indicates 
that increased education on this subject, internationally, may be a beneficial 
intervention.  When observing vaccine attitudes, African American participants 
were statistically more positive about vaccinating their children with the major 
reason against vaccination being a concern for safety (10).  The lack of response 
in the Caribbean population may indicate a cultural obstacle that needs to be 
further researched.  This study also indicated that both populations of people of 
African descent are willing to receive information from medical professionals.  So 
lack of knowledge in minority community, like the African American community, 
may be due to lack of access and not distrust of medical professionals. 
The prevalence of HPV in men ranges from 20% to 65% and is high at all 
ages but appears absolute highest among ages 22-57 (1).  In 2011, the Advisory 
Committee on Immunization Practices recommended that the HPV vaccine to be 
routinely given to males aged 11-21 years; however, its uptake has remained low 
(1).  A study was done on African American and Caribbean boys and their parents 
(1).  The objectives of the study were to describe attitudes and perceptions toward 
acceptability of HPV vaccination among inner-city Caribbean and African 
American adolescent boys and their parents and to identify and discuss 
correlates that may be associated with these factors (1).  This study was done via 
questionnaire asking about socio-demographic characteristics, knowledge of 
HPV and cervical cancer, and attitudes and acceptance towards HPV vaccination 
 56 
(1).  35 surveys were analyzed (1).  Table 18 contains the demographic data of the 
adolescent boys and Table 19 contains the demographic information of the 
parents surveyed.  Although HPV vaccine initiation appeared to be higher for 
those living below the poverty level for boys and girls, vaccine completion rates 
were lower in this group and among African American adolescents (1). Vaccine 
initiation (>/=1 dose) varied substantially among states, with 11.2% in Wyoming 
and 55.2% in Rhode Island (1).  New York City has a lower HPV vaccination at 
greater than 1, greater than 2, and 3 or more doses for both boys and girls 
compared with other cities like Chicago, Washington, DC, and Philadelphia (1).  
These findings suggest the presence of other unknown barriers, which need to 
be identified and addressed.  This is particularly true for teens of ethnic minority 
groups living below the poverty level, who are disproportionately affected.  
Previous studies on girls demonstrated that acceptance of the HPV vaccine is 
mainly guided by motivation to prevent cervical cancer and that education about 
HPV infection significantly increases acceptance of the vaccine.  There is strong 
evidence to show unequal HPV vaccination uptake across various ethnicities. 
 On average, young black women were less likely to initiate the HPV vaccine 
series than were young white women (1).  The method used was a survey (1).  
Male adolescent participants and their parents completed an anonymous, self-
administered questionnaire (1).  The questionnaire elicited information on socio-
demographic characteristics, knowledge of HPV and cervical cancer, and 
attitudes and acceptance toward HPV vaccination (1).  Ninety-two parents were 
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approached for the survey, and 32 declined to participate (1).  An additional 25 
parent surveys containing missing or incomplete data were excluded, leaving a 
total of 35 parent surveys available for analysis (1). 
Table 18-Demographic Data for Adolescent Boys 
 
n% 
Race/Ethnicity 
African American 
Caribbean American 
Hispanic 
Other 
 
65 (64.4) 
29 (28.7) 
4 (4.0) 
3 (3.0) 
Age (yr) 
13-15 
16-17 
>18 
 
16 (15.8) 
37 (36.6) 
48 (47.5) 
Education 
Some high school 
Some college 
High school graduate 
 
71 (72.4) 
19 (19.4) 
8 (8.2) 
Living Situation 
Both parents 
One parent 
Foster parent/guardian 
Emancipated 
Other 
 
32 (31.7) 
53 (52.5) 
6 (5.9) 
2 (1.9) 
8 (7.9) 
Insurance Type 
Medicaid 
Private 
No insurance 
 
70 (75.3) 
22 (23.7) 
1 (1.1) 
Regular Physician 
Yes 
No 
 
82 (81.2) 
19 (18.8) 
Routine Check-ups 
Yes 
No 
 
83 (83.0) 
17 (17.0) 
Note: Reprinted from Shao, Sarah J., et al. “Attitudes and Perceptions of the Human 
Papillomavirus Vaccine in Caribbean and African American Adolescent boys and Their 
Parents.” Journal of Pediatric and Adolescent Gynecology 28 (2015): p. 374. PMC. Web. 
15 June 2018. 
 58 
Table 19-Demographic Data for Parents 
 
N(%) 
Sex 
Male 
Female 
 
6 (17.1) 
29 (82.9) 
Age (yr) 
<40 
41-50 
51-60 
61 and older 
 
16 (47.1) 
12 (35.3) 
5 (14.7) 
1 (2.9) 
Race/ethnicity 
African American 
Caribbean American 
Hispanic 
Caucasian 
Other 
 
19 (55.9) 
12 (35.9) 
1 (2.9) 
1 (2.9) 
1 (2.9) 
Education 
Some high school 
High school graduate 
Some college 
College graduate 
 
7 (20.6) 
12 (35.3) 
10 (29.4) 
5 (14.7) 
Living Situation 
Married 
Single 
Separated/divorced 
Living with partner 
 
14 (40.0) 
13 (37.1) 
6 (17.1) 
2 (5.7) 
 Note: Shao, Sarah J., et al. “Attitudes and Perceptions of the Human Papillomavirus 
Vaccine in Caribbean and African American Adolescent boys and Their Parents.” 
Journal of Pediatric and Adolescent Gynecology 28 (2015): p. 375. PMC. Web. 15 June 
2018. 
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Table 20-Association between Select Demographic and Behavioral 
Characteristics with HPV Knowledge and Vaccine Interest 
Characteristics Know that most cervical cancer is 
caused by HPV? 
Interested in HPV 
vaccination? 
 
Total 
n (%) 
Yes 
n (%) 
No 
n (%) 
P 
value 
Yes 
n (%) 
No 
n (%) 
P 
value 
Race/ethnicity 
African American 
African Caribbean 
Hispanic 
Other 
 
64 (65.3) 
27 (28.7) 
4 (4.0) 
3 (3.0) 
 
17 (63.0) 
8 (29.6) 
2 (7.4) 
0 (0.0) 
 
47 (66.2) 
19 (26.8) 
2 (2.8) 
3 (4.2) 
 
.542 
 
36 (55.4) 
23 (35.4) 
4 (6.2) 
2 (3.0) 
 
25 (83.3) 
4 (13.3) 
0 (0.0) 
1 (3.3) 
 
.049 
Education 
Less than high 
school 
High School or 
more 
 
69 (72.6) 
 
26 (27.4) 
 
12 (50.0) 
 
12 (50.0) 
 
57 (80.3) 
 
14 (19.7) 
 
<.001 
 
42 (70) 
 
18 (30) 
 
59 (78.7) 
 
16 (21.3) 
 
.092 
Gets routine 
medical 
checkups 
Yes 
No 
 
 
83 (83.0) 
17(17.0) 
 
 
23 (88.5) 
3 (11.5) 
 
 
57 (80.3) 
14 (19.7) 
 
 
.348 
 
 
49 (75.4) 
16 (24.6) 
 
 
29 (96.7) 
1 (3.3) 
 
 
.012 
Number of 
lifetime sexual 
partners 
1 to 3 
4+ 
 
 
29 (42.6) 
39 (57.4) 
 
 
8 (42.1) 
11 (57.9) 
 
 
21 (43.8) 
27 (56.2) 
 
 
.903 
 
 
14 (29.2) 
34 (70.8) 
 
 
14 (77.8) 
4 (22.2) 
 
 
<.001 
Frequency of 
condom use 
during sex 
Always 
Sometimes 
 
 
55 (76.4) 
17 (23.6) 
 
 
14 (73.7) 
5 (26.3) 
 
 
39 (76.5) 
12 (23.5) 
 
 
.809 
 
 
34 (68.0) 
16 (32.0) 
 
 
18 (94.7) 
1 (5.3) 
 
 
.021 
Know what HPV 
is 
Yes 
No 
 
65 (64.4) 
36 (35.6) 
 
27(100.0) 
0 (0.0) 
 
35 (49.3) 
36 (50.7) 
 
<.001 
 
47 (71.2) 
19 (28.8) 
 
15 (50.0) 
15 (50.0) 
 
.044 
Note: Reprinted from Shao, Sarah J., et al. “Attitudes and Perceptions of the Human 
Papillomavirus Vaccine in Caribbean and African American Adolescent boys and Their 
Parents.” Journal of Pediatric and Adolescent Gynecology 28 (2015): p. 375. PMC. Web. 
15 June 2018. 
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The study results showed many links between adolescent sexual behavior 
and their interest in HPV vaccination (1).   According to Table 20, higher-risk 
sexual behavior such as inconsistent condom use is significantly associated with 
higher interest in receiving the HPV vaccination (1).   Table 20 also showed that 
having a higher number of sexual partners and a history of past STIs showed a 
marginal increase in adolescent boys' interest in receiving the HPV vaccine (1).  
More frequent routine medical checkups and more consistent condom use are 
independently associated with less interest in HPV vaccine (1). 
The cervical cancer rate is slightly higher than national rates in ethnically 
diverse communities with immigrant populations (18).  The Advisory Committee on 
Immunization Practices recommends the HPV vaccine be routinely given to 9–26 
year old females regardless of sexual activity and prior to HPV infection (18).   
Factors that influence acceptance of the vaccine include knowledge about HPV 
infection and the role of HPV vaccine in cervical cancer prevention, and 
association of HPV with sexual activity, as well as racial and cultural differences 
among attitudes toward and acceptance of the vaccine (18).  The intention to 
vaccinate was associated with more knowledge about HPV and belief that HPV 
vaccine is effective against cervical cancer (18).  The method used for this study 
was an anonymous questionnaire (18).  The questionnaire polled information on 
socio-demographic characteristics, knowledge of HPV and CC, and attitudes 
toward HPV vaccination (18). Questionnaires were obtained from 175 adolescent 
girls and 74 parents, and these groups formed the base sample population for all 
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analyses (18). 
Table 21-Demographic, Health and Sexual Behavior Correlates of Knowledge 
that most Cervical Cancer Caused by HPV and Attitudes Toward HPV 
Vaccination among Girls Attending an Urban Adolescent Clinic in Brooklyn, NY 
  
Know Most Cervical Cancer 
Caused by HPV? 
Interested in HPV 
vaccination? 
Character-
istic 
Total 
N (%) 
Yes 
N (%) 
No 
N (%) 
P-
value 
Yes 
N (%) 
No 
N (%) 
P-
value 
Age (Years) 
13–16 
17–21 
 
97 55.7) 
77 (44.3) 
 
44 (46.3) 
45 (60.8) 
 
51 (53.7) 
29 (39.2) 
 
0.061 
 
37 (38.9) 
36 (52.9) 
 
58 (61.1) 
32 (47.1) 
 
0.076  
Race/ 
Ethnicity 
African 
American 
African 
Caribbean 
Hispanic 
 
 
85(50.6) 
 
66(39.3) 
 
17(10.1) 
 
 
40(48.8) 
 
36(55.4) 
 
10(58.8) 
 
 
42(51.2) 
 
29(44.6) 
 
7(41.2) 
 
 
0.624 
 
 
28 (34.6) 
 
33 (54.1) 
 
11 (64.7) 
 
 
53 (65.4) 
 
28 (45.9) 
 
6 (35.3) 
 
 
0.016 
Education 
Less than 
high school 
High school 
or more 
 
118 (76.1) 
 
37 (23.9) 
 
60 (52.2) 
 
24 (66.7) 
 
55 (47.8) 
 
12 (33.3) 
 
0.127 
 
53 (47.3) 
 
18 (52.9) 
 
59 (52.7) 
 
16 (47.1) 
 
0.566 
Has regular 
doctor 
Yes 
No 
 
 
140(84.3) 
26 (15.7) 
 
 
70 (51.1) 
16 (64.0) 
 
 
67 (48.9) 
9 (36.0) 
 
 
0.234 
 
 
56 (42.7) 
14 (58.3) 
 
 
75 (57.3) 
10 (41.7) 
 
 
0.158 
Gets routine 
medical 
checkups 
Yes 
No 
Don’t know 
 
 
 
128(75.7) 
19 (11.2) 
22 (13.0) 
 
 
 
68 (54.0) 
11 (61.1) 
7 (33.3) 
 
 
 
58 (46.0) 
7 (38.9) 
14 (66.7) 
 
 
 
0.155 
 
 
 
54 (43.5) 
11 (64.7) 
7 (38.9) 
 
 
 
70 (56.5) 
6 (35.3) 
11 (61.1) 
 
 
 
0.219 
Sexually 
Active 
Yes 
No 
 
 
85 (48.9) 
89 (51.1) 
 
 
46 (54.8) 
43 (50.6) 
 
 
38 (45.2) 
42 (49.4) 
 
 
0.587 
 
 
44 (54.3) 
29 (34.9) 
 
 
37 (45.7) 
54 (65.1) 
 
 
0.013 
Number of 
lifetime 
sexual 
partners 
1 
2–4 
5+ 
 
 
 
 
32 (40.5) 
34 (43.0) 
13 (16.5) 
 
 
 
 
12 (38.7) 
20 (58.8) 
10 (76.9) 
 
 
 
 
19 (61.3) 
14 (41.2) 
3 (23.1) 
 
 
 
 
0.050 
 
 
 
 
13 (41.9) 
22 (71.0) 
7 (53.8) 
 
 
 
 
18 (58.1) 
9 (29.0) 
6 (46.2) 
 
 
 
 
0.070 
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Ever had 
STD 
Yes 
No 
 
 
24 (27.0) 
65 (73.0) 
 
 
14 (60.9) 
34 (52.3) 
 
 
9 (39.1) 
31 (47.7) 
 
 
0.478 
 
 
13 (56.5) 
34 (56.7) 
 
 
10 (43.5) 
26 (43.3) 
 
 
0.990 
Frequency of 
condom use 
during sex 
Always 
Sometimes 
 
 
 
48 (63.2) 
28 (36.8) 
 
 
 
29 (60.4) 
15 (53.6) 
 
 
 
19 (39.6) 
13 (46.4) 
 
 
 
0.560 
 
 
 
26 (57.8) 
17 (63.0) 
 
 
 
19 (42.2) 
10 (37.0) 
 
 
 
0.664 
Know what 
HPV is 
Yes 
No 
 
 
96 (55.8) 
76 (44.2) 
 
 
80 (84.2) 
9 (12.0) 
 
 
15 (15.8) 
66 (88.0) 
 
 
<0.001 
 
 
57 (61.3) 
16 (23.2) 
 
 
36 (38.7) 
53 (76.8) 
 
 
<0.001 
Note: Reprinted from Read, Dalan S., et al. “Attitudes and Perceptions of the HPV 
Vaccine in Caribbean and African-American Adolescent Girls and their Parents.” The 
Journal of Pediatric and Adolescent Gynecology (2010) 23:244. PMC. Web. 15 June 
2018. 
 Table 21 shows that African American females were more knowledgeable 
about the HPV vaccine yet were less interested in getting vaccinated than Afro-
Caribbean participants.  Not knowing enough about the vaccine itself was the 
main reason found for disinterest in getting vaccinated against HPV.  This study 
shows that not only is knowledge on HPV important for increasing vaccine 
uptake but background information on the vaccine itself would likely increase 
vaccine uptake in the African American community. 
 
Discussion 
 This comparison of studies was conducted based upon the fact that many 
ethnic minorities are affected at different rates, in reference to their White 
counterparts, by disease.  This phenomenon occurs across the U.S. and in other 
countries as well.  This compilation of studies focuses on African Americans.  It is 
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important to examine how and why African Americans are disproportionately 
affected by HPV related cancers.  In order to do that, group attitudes and 
perception of the virus and its vaccine must be understood.  An understanding of 
how African Americans view HPV will allow medical professionals to develop 
interventions catering to the African American communities. 
 Studies show that human papillomavirus infection and cervical cancer 
rates are higher in African American communities.  However, a decrease in these 
rates has been observed overtime since the approval of HPV vaccines.  From 
2008 – 2013, disparities in the recommendation of the HPV vaccine to African 
American women decreased.  A decrease of similar nature was seen in African 
American men, since the vaccine has become available to them.  Access to 
medical professionals is one of the causes of low vaccination rates.  Neglect of 
health care providers to provide HPV and vaccine information are another reason 
for low vaccine rates in the African American community.  More studies should 
be done to fully comprehend what contributors to the lack of HPV vaccination 
recommendation to African American men and women.   
 With increased recommendation of the HPV vaccine, there has been 
increase in vaccine uptake in the African American community.  This showed that 
Black people do not necessarily distrust the information from healthcare 
providers.  In fact in many studies African Americans stated that their physician 
or healthcare provider was their most trusted source of information.  Getting 
vaccinated against HPV is simply a matter of whether they are able to receive 
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enough information.  Everyone involved in the vaccination process must be 
properly educated.  African Americans must be educated on the benefits of the 
HPV vaccine, the range of cancers human papillomavirus can cause and the 
severity of these cancers.  Medical professionals and providers must be culturally 
educated on how to best distribute and communicate the necessary information.  
The more research done on how this community comprehends medical 
information and how they perceive and understand HPV, the more likely they will 
be to receive HPV and HPV vaccine information.  This will ultimately increase 
vaccine uptake, as being knowledgeable about HPV has been shown to 
positively correlate to increased vaccine uptake. 
 Historically, African Americans have been among the minorities that were 
disproportionately devastated by cervical cancer.  Overtime, cervical cancer rates 
have dropped faster in the African American community than in the White 
community.  This drop could be due to an active increase in efforts to inform the 
African American community about HPV and aspects of the virus and the 
benefits of the vaccine.  Knowledge about cervical cancer and its correlation to 
HPV relates to higher vaccine uptake in the African American community.   
When informed about HPV, young African Americans are more likely to 
get vaccinated.  If they choose not to initiate the vaccine series, in spite of being 
informed, it is often due to the ideals of their parents. So, it is important that HPV 
interventions be normalized in the Black community and that they are geared 
towards all age groups.  There are currently not a lot of interventions geared 
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specifically towards African Americans of age to be vaccinated. With more 
research, measures to change this can be taken. 
 Availability of the vaccine does not seem to be a barrier of uptake.  It is 
truly a matter of the amount of information that those eligible for the vaccine and 
their parents have.  Studies show that more information leads to greater 
compliance of parents to vaccinate their children and of patients to get 
vaccinated. 
 There are still areas of the U.S. that lack access to information about HPV.  
These areas have not seen decreases in African American cervical cancer 
prevalence.  In areas, where information availability is already low, African 
Americans lack important knowledge about HPV and suffer, at greater rates from 
HPV-related cancers.  
 In religious African American communities, older age is connected to less 
intention to vaccinate and less knowledge about HPV and HPV-related cancers.  
Older age, in these communities, is also connected to less support of vaccinating 
adolescents against HPV.  The younger, church going African American 
community is more compliant with HPV vaccination and more knowledgeable.  
Those with less formal education, in the African American church community 
were more compliant, as well.  Being informed on HPV and HPV related cancer 
is a matter of both attitude and perception.  The fact that HPV is a sexually 
transmitted disease and the prophylactic vaccine is recommended to teenagers 
raises concern in the older religious community.  This groups views both the virus 
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and vaccine as negative due to the religious implications. 
 African Americans are less informed about the human papillomavirus and 
are more affected by it in the U.S.  When compared to their Haitian and 
Caribbean counterparts, African Americans are found to be more informed and 
more vaccinated.  So, African Americans are at an advantage when compared to 
other people of African descent internationally.  
 The overwhelming theme is that knowledge about human papillomavirus, 
the human papillomavirus vaccine and human papillomavirus related cancers 
can greatly decrease HPV-cancer related incidence in the African American 
community.  The vaccine could decrease social disparities in HPV infection and 
cervical cancer mortality, as long as it is distributed evenly amongst all ethnic 
communities.  The entire African American community needs to be informed on 
the severity of HPV-related cancers and the effectiveness of the vaccine in 
preventing transmission of cancer causing strains.  More information will better 
perception vaccine and attitudes towards it in the community. Ethnically and 
culturally sensitive interventions should be developed and normalized.  Increased 
vaccine uptake will substantially decrease healthcare cost and burden in the long 
run as HPV cancer rates decrease in the vaccinated population. 
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